A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott B. Phillips, M.D.
Winston Laboratories
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Valley Neurological Headache & Research Center
Phoenix, Arizona, United States
- Neurological Associates of Tucson
Tucson, Arizona, United States
- Northern California Headache Clinic
Mountain View, California, United States
- San Francisco Clinical Research Center
San Francisco, California, United States
- California Medical Clinic for Headache
Santa Monica, California, United States
- New England Center for Headache, Pc
Stamford, Connecticut, United States
- Neurology Clinical Research, Inc.
Plantation, Florida, United States
- Neurology and Headache Specialists of Atlanta
Decatur, Georgia, United States
- Diamond Headache Clinic
Chicago, Illinois, United States
- Boston Clinical Research Center
Wellesley Hills, Massachusetts, United States
- Michigan Headache Pain & Neurological Institute
Ann Arbor, Michigan, United States
- Henry Ford Hospital Department of Neurology
Detroit, Michigan, United States
- Department of Neurology Mayo Clinic
Rochester, Minnesota, United States
- Mercy Health Research
Chesterfield, Missouri, United States
- Headache Care Center/clinvest
Springfield, Missouri, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- New York Headache Center
New York, New York, United States
- the Headache Wellness Center
Greensboro, North Carolina, United States
- Cincinnati Headache Clinic
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Neurological Associates of Tulsa, Inc.
Tulsa, Oklahoma, United States
- Jefferson Headache Center
Philadelphia, Pennsylvania, United States
- Nashville Neuroscience Center
Nashville, Tennessee, United States
- Houston Headache Clinic
Houston, Texas, United States
- the Neurology and Headache Treatment Center (innovative Clinical Research)
Alexandria, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2002
- Primary completion
- 31 Jul 2003
- Completion
- 31 Jul 2003
- Last update posted
- 10 Jun 2011
- Registered enrollment
- 60
- Registry id
- NCT00033839
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.